Arlington Trust’s AbbVie ABBV Stock Holding History

Arlington Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$289K	Buy	1,150 +286	+33%	+$61.5K	0.02%	86
2026 Q1	$188K	Buy	864 +334	+63%	+$74.1K	0.02%	101
2025 Q4	$121K	Sell	530 -5,249	-91%	-$1.2M	0.01%	125
2025 Q3	$1.34M	Hold	5,779	–	–	0.24%	53
2025 Q2	$1.07M	Sell	5,779 -197	-3%	-$36.6K	0.21%	62
2025 Q1	$1.25M	Sell	5,976 -802	-12%	-$156K	0.27%	52
2024 Q4	$1.2M	Buy	6,778 +100	+1%	+$18.4K	0.25%	53
2024 Q3	$1.32M	Buy	6,678 +40	+0.6%	+$7.46K	0.29%	48
2024 Q2	$1.14M	Buy	6,638 +1,588	+31%	+$263K	0.27%	53
2024 Q1	$920K	Sell	5,050 -150	-3%	-$25.9K	0.24%	57
2023 Q4	$806K	Buy	+5,200	New	+$758K	0.23%	62

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Arlington Trust's ABBV Position: Q2 2026 in Review

Arlington Trust increased its AbbVie (ABBV) stake by 33% in Q2 2026, buying an estimated $61.5K and bringing the position to 1,150 shares worth $289K. The position accounts for 0.02% of the portfolio, ranked #86.

Arlington Trust first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.34M in Q3 2025. 801 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Arlington Trust held 1,150 shares of AbbVie worth $289K as of Q2 2026.
Arlington Trust bought 286 AbbVie shares in Q2 2026, an estimated $61.5K.
AbbVie made up 0.02% of Arlington Trust's portfolio in Q2 2026, its #86 holding.
Arlington Trust first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Arlington Trust's AbbVie position peaked at $1.34M in Q3 2025.
801 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.